DAGNA, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 2.557
NA - Nord America 1.840
AS - Asia 1.353
AF - Africa 27
OC - Oceania 23
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.827
Nazione #
US - Stati Uniti d'America 1.818
SE - Svezia 1.083
IT - Italia 700
CN - Cina 635
SG - Singapore 519
RU - Federazione Russa 349
FI - Finlandia 112
DE - Germania 92
IN - India 62
IE - Irlanda 48
GB - Regno Unito 46
NL - Olanda 31
PH - Filippine 23
CA - Canada 18
HK - Hong Kong 18
TR - Turchia 18
AU - Australia 16
FR - Francia 14
JP - Giappone 14
IR - Iran 12
NO - Norvegia 12
UA - Ucraina 12
ES - Italia 11
MA - Marocco 11
IL - Israele 10
PK - Pakistan 10
BR - Brasile 9
PE - Perù 9
AT - Austria 7
BE - Belgio 7
NZ - Nuova Zelanda 7
ZA - Sudafrica 7
DK - Danimarca 5
EU - Europa 5
MY - Malesia 5
KR - Corea 4
MK - Macedonia 4
MX - Messico 4
PT - Portogallo 4
SA - Arabia Saudita 4
AR - Argentina 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GR - Grecia 3
MO - Macao, regione amministrativa speciale della Cina 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
DZ - Algeria 2
ID - Indonesia 2
LB - Libano 2
PL - Polonia 2
QA - Qatar 2
RO - Romania 2
TG - Togo 2
TN - Tunisia 2
AL - Albania 1
BD - Bangladesh 1
EC - Ecuador 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ME - Montenegro 1
SI - Slovenia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 5.827
Città #
Singapore 342
Shanghai 281
Lawrence 278
Princeton 278
New York 209
Ashburn 204
Milan 181
Moscow 171
Boardman 121
Helsinki 97
Rome 60
Dublin 43
Dallas 37
Los Angeles 37
Pune 37
Seattle 36
Guangzhou 32
Washington 30
Ancona 22
Beijing 17
Florence 15
Shenzhen 15
Vaprio d'Adda 15
Hong Kong 14
Lappeenranta 14
London 14
Jiaxing 13
Rotterdam 13
Turin 13
Santa Clara 11
Bologna 9
Makati City 9
Xi'an 9
Genoa 8
Oslo 8
Pisa 8
Bergamo 7
Cagliari 7
Cape Town 7
Galliate 7
Istanbul 7
Ankara 6
Hanover 6
Lahore 6
Manchester 6
Melbourne 6
Padova 6
Quanzhou 6
Redwood City 6
Taizhou 6
Auckland 5
Brussels 5
Buffalo 5
Kassel 5
Khemisset 5
Miraflores District 5
Mountain View 5
Munich 5
Osimo 5
Pamplona 5
Quezon City 5
Saint Louis 5
St Petersburg 5
São Paulo 5
Toronto 5
Verona 5
Vittoria 5
Wuxi 5
Amsterdam 4
Arezzo 4
Atlanta 4
Borås 4
Brisbane 4
Catania 4
Dalmine 4
Falkenstein 4
Foshan 4
Gatchina 4
Goito 4
Hyderabad 4
Indianapolis 4
Mestrino 4
Minerbio 4
Nantong 4
Nellore 4
Perugia 4
San Francisco 4
Seoul 4
Trondheim 4
York 4
Acate 3
Amadora 3
Angera 3
Athens 3
Ballincollig 3
Cabanatuan City 3
Casablanca 3
City of Westminster 3
Clifton 3
Falconara Marittima 3
Totale 2.998
Nome #
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 158
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 68
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 48
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 46
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 43
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 41
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 41
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 41
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 40
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 39
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 39
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 38
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 38
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 37
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 36
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 36
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 35
Testosterone in males with COVID-19: A twelve-month cohort study 34
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 34
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 33
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 33
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 33
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database 32
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 32
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 32
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 31
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 31
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 31
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 30
Anti-TNF alpha agents in Takayasu's arteritis: An Italian experience 30
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 30
Biobanking for COVID-19 research 30
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 30
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Obesity and its role in the management of rheumatoid and psoriatic arthritis 29
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients 29
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 28
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 28
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 28
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 27
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 27
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 27
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 26
C3-glomerulopathy and MGUS: The skin beyond the kidney 26
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series 26
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis 26
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 26
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 26
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 26
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 26
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 26
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 25
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 25
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 25
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 25
Systemic lupus erythematosus and COVID-19: what we know so far 25
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 25
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 25
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 25
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 24
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 24
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 24
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 24
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial 23
Advances in potential targeted therapies for Erdheim-Chester disease 23
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study 23
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 23
A Novel Histiocytosis With Synovial and Skin Involvement 23
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 23
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 23
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 23
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 23
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 22
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 22
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 22
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 22
Anakinra for patients with COVID-19 – Authors' reply 22
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 22
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 22
Drug retention rates of biological agents in adult onset Still's disease 22
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? 22
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 21
Clinically isolated aortitis successfully treated with methotrexate monotherapy 21
Therapeutic strategies for virus-negative myocarditis: a comprehensive review 21
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 21
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 21
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 20
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 20
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 20
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 20
Urgent manifestations of immunoglobulin G4-related disease 20
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 20
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias 20
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 20
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 20
Totale 2.945
Categoria #
all - tutte 92.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 6 0 1 0 38 2
2020/2021119 6 0 13 8 1 27 31 6 6 4 13 4
2021/2022431 3 0 101 78 26 27 33 26 42 37 30 28
2022/20232.173 652 435 141 21 36 244 219 209 101 39 40 36
2023/20242.241 79 135 231 200 184 371 118 204 18 92 210 399
2024/20251.430 638 146 220 243 183 0 0 0 0 0 0 0
Totale 6.503